World Heart Day | professional know "heart", science and technology to protect the "heart"!
Heart diseaseis a threatThe "number one killer" of human health"It is the leading cause of death worldwide. According to the WHO, 17.9 million people died from cardiovascular disease in 2019, accounting for 32% of all deaths worldwide. Of these deaths, 85 per cent were due to heart attacks and strokes. In 2018, cardiovascular deaths accounted for the first cause of total deaths among urban and rural residents in my country, with 46.66 per cent in rural areas and 43.81 per cent in urban areas. In 2020, the number of cardiovascular patients was about 0.33 billion.
Due to the widespread prevalence of unhealthy diet, lack of exercise, smoking and other lifestyles,The number of people suffering from hypertension, dyslipidemia, diabetes and obesity in China is still rising, and the prevalence and mortality of cardiovascular disease are increasing year by year.
To maintain cardiovascular health, it is extremely important to take effective preventive measures,To achieve early detection, early treatment in order to reduce the mortality of cardiovascular disease.
What is cardiovascular disease?
The basic pathological changes of cardiovascular disease are caused by stenosis or occlusion of vascular lumen, which are common:
Coronary heart disease-- Diseases of the blood vessels supplying the myocardium
Cerebrovascular disease-Diseases of the blood vessels supplying the brain
peripheral peripheral arterial vascular disease-Diseases of the blood vessels supplying the arms and legs
rheumatic heart disease-Damage to the myocardium and heart valves due to rheumatic fever caused by streptococci
Congenital heart disease-- Structural abnormalities of the heart present at birth
Deep vein thrombosis and pulmonary embolism-- Blood clots in the veins of the legs, which can break off and move to the heart and lungs.
Heart attacks and strokes are common among cardiovascular diseases, which are mainly caused by clogged arteries that stop blood from flowing to the heart or brain. For example, blood clots in internal arteries, cholesterol plaques, etc., and when blood vessels in the brain rupture and blood leaks into the surrounding tissues can also cause stroke.
What are the risk factors for cardiovascular disease?
Cardiovascular disease morbidity and mortality are extremely high, but these diseases can be prevented by changing lifestyle habits.The main risk factors for cardiovascular disease are high cholesterol, high blood pressure, high blood lipids, smoking, diabetes and obesity.The presence of these risk factors increases the risk of heart attack, stroke, heart failure and other complications.
In additionPsychological stress, depression, geneticsfactors will also increase the risk of cardiovascular disease.
At present, studies have shown that smoking cessation, reducing dietary salt intake, increasing the proportion of fruits and vegetables in the diet, proper physical exercise, and abstinence from alcohol can reduce the risk of cardiovascular disease in patients.
In addition, patients who already have diabetes, hypertension and hyperlipidemia need to take reasonable drug treatment. Controlling these basic diseases can also reduce the risk of cardiovascular disease and prevent heart attack and stroke.
How to reduce the burden of cardiovascular disease?
Lifestyle changes to achieve and maintain a healthy weight can have a beneficial effect on risk factors (blood pressure, blood lipids, glucose metabolism) and reduce the risk of cardiovascular disease.
For some patients with basic diseases, when the effect of non-invasive interventions is not good, drugs can be used to prevent cardiovascular diseases. Specific as follows:
Statins as drugs to reduce cardiovascular risk in individuals at high risk for hypertriglyceridemia;
The use of RAS-based blockers (ACEI/ARB) combined with calcium antagonists (CCB) or thiazide/thiazide-like diuretics in patients with hypertension, and other combinations of the five categories of drugs can also be used;
Metformin is recommended as first-line therapy for type 2 diabetes and dapagliflogin is recommended for type 1 diabetes;
Patients with established atherosclerotic cardiovascular disease require low-dose aspirin antiplatelet therapy for secondary prevention.
Guardian heart health, we are in action
Guangdong Weishi Biology pays close attention to the trend of cardiovascular disease, adheres to the concept of "pursuing excellence, only truth and reality", attaches importance to product upgrading and research and development, and innovatively launched a series of cardiovascular diagnostic reagent products to protect heart health.
Guangdong only real biological cardiovascular diagnostic reagent products:
High Sensitivity Cardiac Troponin I(cTnI) ELISA Kit
N-terminal pro-brain natriuretic peptide (NT-proBNP) detection kit (immunofluorescence method)
Creatine kinase isoenzyme (CK-MB) detection kit (immunofluorescence method)
Heart fatty acid binding protein (H-FABP) detection kit (immunofluorescence method)
Myoglobin (Myoglobin) detection kit (immunofluorescence method)
Myocardial infarction triple test (cTnI/CK-MB/Myo) detection kit (immunofluorescence method)
Guangdong only real biological cardiovascular diagnostic reagent products 4 advantages:
Fast: the results of single examination will be obtained within 8mins, meeting the testing time requirements of critical and severe cases and 5 major centers.
Precision: large equipment imported from the central laboratory, r≥ 0.95
Sensitive: the minimum detection limit of characteristic project hs-cTnI is 20pg/mL, and the detection rate of normal people is more than or equal to 50%
Convenient: the same reagent card is suitable for serum, plasma and whole blood samples, and the sample addition amount and incubation time are the same, with excellent user experience.
If you are interested in the cardiovascular diagnostic reagent products independently developed by Guangdong Weishi Bio, welcome to contact us through the following ways!
WHO.Cardiovascular diseases (CVDs).World Health Organization, 2021.
 Summary of China Cardiovascular Health and Disease Report 2020
2021 ESC Guidelines: Prevention of Cardiovascular Disease in Clinical Practice